术前血红蛋白作为择期全髋关节置换术后并发症的连续预测指标
该研究利用医疗数据库纳入2016至2023年25,654例择期全髋关节置换术患者,以术前28天内血红蛋白为连续变量,采用限制性立方样条和多变量逻辑回归分析。发现血红蛋白与假体周围关节感染及内科、外科并发症风险呈非线性关联,鉴定了13.5 g/dL和13.3 g/dL的拐点,低于拐点时风险逐级增加。作者认为拐点应供参考而非决定手术资格,需进一步研究纠正贫血是否降低并发症风险。
要点
- 术前血红蛋白与全髋置换术后90天假体周围关节感染风险呈非线性关联,拐点为13.5 g/dL。
- 血红蛋白11.0 g/dL和8.0 g/dL者较13.5 g/dL者假体周围关节感染风险分别增加1.91倍和4.40倍。
- 低于拐点时每降低0.5 g/dL,假体周围关节感染相对风险呈阶梯式上升。
核心结论
- 贫血严重程度与全髋关节置换术后假体周围关节感染、内科及外科并发症风险的非线性增加相关。
- 鉴定的拐点应供参考而非决定手术资格,可能支持个体化优化。
- 需进一步研究确定纠正贫血是否降低并发症风险。
研究设计与样本
- 利用医疗数据库识别2016至2023年间所有初次全髋关节置换术患者,要求术前28天内有血红蛋白值。
- 共纳入25,654例全髋关节置换术,其中126例(0.5%)在术后90天内发生假体周围关节感染。
- 采用多变量逻辑回归联合限制性立方样条评估血红蛋白作为连续预测变量,并用Metropolis-Hastings bootstrap模拟识别拐点。
主要发现
- 限制性立方样条分析识别假体周围关节感染和汇总内科并发症的血红蛋白拐点为13.5 g/dL,汇总外科并发症拐点为13.3 g/dL。
- 与血红蛋白13.5 g/dL相比,血红蛋白11.0 g/dL者假体周围关节感染风险增加1.91倍(95%CI:1.37至2.68),血红蛋白8.0 g/dL者增加4.40倍(95%CI:1.91至10.14)。
- 低于拐点时,相对风险呈阶梯式增加,血红蛋白从13.5降至12.0 g/dL、从12.0降至11.0 g/dL、从11.0降至10.0 g/dL,每降低0.5 g/dL平均增加分别为14.9%、23.2%和30.7%。
- 在这些范围内,血红蛋白每降低一个单位,汇总内科和外科并发症风险也观察到类似的递增。
关键数值与推荐
- 假体周围关节感染和汇总内科并发症的血红蛋白拐点为13.5 g/dL,汇总外科并发症拐点为13.3 g/dL。
- 血红蛋白11.0 g/dL相比13.5 g/dL,假体周围关节感染风险增加1.91倍(95%CI:1.37至2.68)。
- 血红蛋白8.0 g/dL相比13.5 g/dL,假体周围关节感染风险增加4.40倍(95%CI:1.91至10.14)。
- 血红蛋白从13.5降至12.0 g/dL、从12.0降至11.0 g/dL、从11.0降至10.0 g/dL,每降低0.5 g/dL假体周围关节感染相对风险平均增加分别为14.9%、23.2%和30.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究确定纠正贫血是否降低并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative anemia is associated with adverse outcomes following total hip arthroplasty (THA). However, discrete hemoglobin thresholds may obscure potentially meaningful relationships between anemia severity and postoperative risk. This study assessed preoperative hemoglobin as a continuous variable to predict periprosthetic joint infection (PJI), medical, and surgical complications following elective THA. METHODS: A health care database was utilized to identify all primary THA patients between 2016 and 2023 with a hemoglobin value available within 28 days preoperatively. The primary outcome was PJI within 90 days of surgery. The secondary outcomes included 90-day aggregate medical and surgical complications. Multivariable logistic regressions with restricted cubic splines (RCS) evaluated hemoglobin as a continuous predictor of postoperative risk. Changepoints were identified using a Metropolis-Hastings bootstrap simulation. In total, 25,654 THAs were included, of which 126 (0.5%) developed PJI within 90 days. RESULTS: The RCS analysis identified hemoglobin changepoints of 13.5 g/dL for PJI and aggregate medical complications and 13.3 g/dL for aggregate surgical complications. Compared to 13.5 g/dL, patients who had hemoglobin values of 11.0 and 8.0 g/dL had a 1.91-fold (95% confidence interval (CI): 1.37 to 2.68) and 4.40-fold (95% CI: 1.91 to 10.14) increased risk of PJI, respectively. Below the identified changepoint, relative risk increased in a stepwise manner, with average increases of 14.9, 23.2, and 30.7% observed for each 0.5 g/dL decrement from 13.5 to 12.0, 12.0 to 11.0, and 11.0 to 10.0 g/dL, respectively. A similar incremental increase in risk was observed for aggregate medical and surgical complications with each hemoglobin decrement across these ranges. CONCLUSIONS: Anemia severity is associated with a nonlinear increase in the risk of PJI, medical, and surgical complications following THA. Identified changepoints should inform, not dictate, surgical eligibility and may support individualized optimization. Further research is needed to determine whether anemia correction reduces complication risk.
引用
- Palmer RC, Lim MA, Telang SS, et al. Preoperative Hemoglobin as a Continuous Predictor of Postoperative Complications Following Elective Total Hip Arthroplasty. J Arthroplasty. 2025. PMID: 41207339. doi:10.1016/j.arth.2025.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。